Yi Fang

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Diabetic Nephropathy

Transforming Growth Factor

Top Venues

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Oxidative medicine and cellular longevity

Journal of immunology research

Journal of diabetes research

This page only lists publications with an associated author ORCID identifier.

Publications

Da-Xi Wang, Si-Yu Bao, Na-Na Song, Wei-Ze Chen, Xiao-Qiang Ding, Robert J Walker, Yi Fang
FTO-mediated m6A mRNA demethylation aggravates renal fibrosis by targeting RUNX1 and further enhancing PI3K/AKT pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (5) (2024)
Da-Xi Wang, Si-Yu Bao, Na-Na Song, Wei-Ze Chen, Xiao-Qiang Ding, Robert J Walker, Yi Fang
FTO-mediated m6A mRNA demethylation aggravates renal fibrosis by targeting RUNX1 and further enhancing PI3K/AKT pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (5) (2024)
Sujuan Xu, Edward Lee, Zhaoxing Sun, Xiaoyan Wang, Ting Ren, Zhouping Zou, Jifu Jin, Jie Li, Jian Zhang, Yingxiang Li, Qiang Yang, Yang Zhang, Man Guo, Yi Fang, Xiaoqiang Ding
Perilipin 2 Impacts Acute Kidney Injury via Regulation of PPARα. Journal of immunology research 2021 (2021)
Yiran Liang, Ning Xue, Xiaoyan Wang, Xiaoqiang Ding, Yi Fang
Superagonistic CD28 protects against renal ischemia injury induced fibrosis through a regulatory T-cell expansion dependent mechanism. BMC nephrology 20 (1) (2019)
Ziyan Shen, Yi Fang, Tao Xing, Feng Wang
Diabetic Nephropathy: From Pathophysiology to Treatment. Journal of diabetes research 2017 (2017)
Yi Fang, Ting Xie, Ning Xue, Qing Kuang, Zheng Wei, Mingyu Liang, Xiaoqiang Ding
miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1. Oxidative medicine and cellular longevity 2017 (2017)